Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 148 (RNA5SP148) is a processed pseudogene derived from the 5S ribosomal RNA gene. Pseudogenes arise through duplication or retrotransposition events and often acquire disruptive mutations that prevent them from producing functional RNA or protein products. While the functional 5S rRNA is a core structural component of the large ribosomal subunit and is essential for protein synthesis, the pseudogene lacks this capacity, typically due to sequence mutations, lack of necessary regulatory elements, or genomic context[1][2][4][5]. In general, rRNA pseudogenes such as RNA5SP148 do not play an active role in ribosome function, drug targeting, or therapeutic intervention. Some pseudogenes in other families may be transcribed and assume a regulatory role, but no such function is described for this specific pseudogene.
Not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 148 (RNA5SP148).